Search

everythinglearnresearchcommunity

for

Search:↓

Women with severe acne, hirsutism, and androgenic alopecia often have higher levels of certain androgens, but the specific pattern can't be predicted just by looking at symptoms.

A 20-month-old girl had a rare adrenal tumor removed successfully, with no recurrence for 10 years.

Rare ovarian tumors can cause hyperandrogenism, even if imaging appears normal.

Female hair loss is influenced by genetics and hormones, often starting in middle age or after hormonal changes.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Men generally have higher blood pressure than premenopausal women, but postmenopausal women's blood pressure can surpass men's, and hormone therapy doesn't significantly help.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

Enzyme activities do not cause early pubic hair in these girls.

Most postmenopausal women experience significant skin changes and various skin conditions.

Hair loss in postmenopausal woman caused by ovarian issue.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

A man's adrenal insufficiency was caused by a pituitary tumor linked to kidney cancer.

Antiandrogen therapy may be beneficial for women with hidradenitis suppurativa.

DHEA supplementation may improve quality of life, neuropsychological functions, and sexual satisfaction in individuals with adrenal insufficiency, but more research is needed to confirm its safety and effectiveness.

Female hyperandrogenism is a condition caused by too much male hormones, leading to skin issues and ovulation problems, often due to Polycystic Ovary Syndrome, and is treated based on individual symptoms.

A rare adrenal tumor in a woman only made DHEA-S, causing hair thinning, and was removed, fixing the hormone level.

A woman developed male characteristics after using unregulated hormone therapy.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Adrenalin may help reduce hair fall and dandruff linked to stress in adventure sports enthusiasts.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

The conclusion is that more women in their forties are getting AGA and stress is linked to AGA in both men and women.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

A woman's high testosterone and related symptoms were caused by overactive cells in her ovaries.

The foreword introduces a medical issue discussing male hormonal health, treatments, and the effects of conditions like obesity and aging.

Cortisone reductase deficiency can cause high androgen and cortisol levels and may be missed in women with similar symptoms.

Leydig cell tumors can cause high testosterone and symptoms in postmenopausal women, and removing them improves symptoms.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.